Health Organisation death covid-19 record patient Health Organisation

Hydroxychloroquine trial halted after 'failure to reduce Covid-19 deaths'

Reading now: 593
www.mirror.co.uk

Trials of hydroxychloroquine on coronavirus patients have been halted after they failed to reduce mortality. The malaria drug and a combination HIV drug lopinavir/ritonavir was trialled on patients infected with Covid-19.

In a statement, the World Health Organisation said: “These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised Covid-19 patients when compared to standard of care." Referring to large multi-country trials that the agency is leading, the WHO added: "Solidarity trial investigators will interrupt the trials with immediate effect".

Read more on mirror.co.uk
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA